Company Filing History:
Years Active: 2005
Title: The Innovative Contributions of Daniel S O'Connor
Introduction
Daniel S O'Connor is a notable inventor based in Brooklyn Heights, NY. He has made significant contributions to the field of cancer treatment through his innovative research and patent. His work focuses on enhancing the effectiveness of chemotherapy, particularly in the context of taxane-based therapies.
Latest Patents
Daniel S O'Connor holds a patent titled "Enhancement of taxane-based chemotherapy by a CDK1 antagonist." This invention provides a combination therapy aimed at inhibiting tumor growth, treating cancer, and inducing cell death. The therapy involves the sequential administration of taxane and a CDK1 antagonist. Additionally, the patent includes pharmaceutical compositions and kits that comprise both taxane and the CDK1 antagonist.
Career Highlights
O'Connor is affiliated with Yale University, where he conducts his research and development in the field of oncology. His work has garnered attention for its potential to improve cancer treatment outcomes.
Collaborations
One of his notable collaborators is Dario C Altieri, with whom he has worked on advancing cancer therapies.
Conclusion
Daniel S O'Connor's innovative approach to cancer treatment through his patent demonstrates his commitment to improving patient outcomes. His contributions to the field are invaluable and highlight the importance of continued research in oncology.